Therapeutics News

In a prospective trial, patients treated with oral valproic acid for autosomal dominant retinitis pigmentosa had worse visual field outcomes than patients treated with placebo.

LAS VEGAS – Jim Thimons, OD, spoke here at Vision Expo West on the top 10 oral agents used in optometric practice.

Prolonged anticholinergic drug use may be associated with a risk of late age-related macular degeneration, according to a study.

Ten years ago, the prevailing sentiment among anterior segment surgeons was that the best way to prevent infection from aggressive bacteria was to use “fourth-generation” fluoroquinolone eye drops.

A 26-year-old Caucasian female presented to our clinic for evaluation with one of our colleagues. Her chief complaint at that exam was a recent onset of near vision blur only, which she felt was slightly worse in the right eye for several weeks. She described the blur as being constant with no fluctuations. In addition, she also stated she was not experiencing any headaches or double vision.

“I don’t think we really know the prevalence of bacterial vs. viral conjunctivitis,” Spencer D. Johnson, OD, FAAO,told Primary Care Optometry News in an interview.

The FDA is warning health care professionals not to use sterile drug products from Ranier’s Compounding Laboratory due to lack of sterility assurance.

DENVER – Whitney Hauser, OD, shared results of a study here at Optometry’s Meeting where she evaluated long-term IOP control in patients receiving one, two or three microbypass stents.

DENVER – Clark Chang, OD, MSA, MSc, FAAO, shared take-home pearls from his two presentations on corneal cross-linking and contact lens fitting after CXL at Optometry's Meeting.

Eyenovia Inc. has announced that two additional patent applications have received Notices of Allowance from the U.S. Patent and Trademark Office.